Date Published:
19 May 2009 |
UN, WHO heads meet vaccine manufacturers
WHO Director-General Dr Margaret Chan and United Nations Secretary-General
Ban Ki-moon met with over 30 vaccine manufacturers from developing and developed
countries at WHO headquarters today.
Both the Director-General and the Secretary-General stressed the importance
of assuring that any eventual vaccine for Influenza A(H1N1) was made available
in a spirit of equity and fairness, and invited the manufacturers to continue
to work with them to develop a strategy for this. Industry representatives affirmed
their wish to cooperate in making supplies available to developing countries,
and said they stood ready to produce the vaccine when requested.
At a press conference later in the day, Dr Chan said:
"We have a very serious commitment from companies in the North and
in the South to work with WHO." She said the Secretary-General's
ability to mobilize resources "is extremely vital when the world
is under threat of an imminent pandemic." Together with the UN and other
members of the global community, WHO would work to find innovative funding
mechanisms to ensure that developing countries were not denied access to vaccines
because of lack of means.
Both the Director-General and Secretary-General expressed their appreciation
of the efforts of the manufacturers, with support from governments, to further
increase their production capacity.
Although WHO was not a funding agency, Dr Chan said she took it as part of
her job to advocate for the poor.
"In the name of solidarity, I have reached out to drug and vaccine
manufacturers," she said. "We will look at different mechanisms
to make sure poor communities and countries are not left out."
She said she had spoken with UNITAID, GAVI the World Bank and foundations to
continue work on funding. The Director-General said she would meet with vaccine
manufacturers individually to work out strategies to ensure pandemic vaccine
availability.
In response to a question on pandemic alert phase change, Dr Chan explained
that the definition of WHO's influenza preparedness phases was developed against
the backdrop of H5N1 avian flu. Influenza A(H1N1) has a very different clinical
picture, which is so far mostly mild and self-limiting, unlike H5N1, which had
a 50% to 60% mortality rate. She said that at the on-going World Health Assembly,
Member States had asked that WHO reflect criteria other than geographical spread
before moving to Phase 6. The pandemic alert level is currently at Phase 5.
Secretary-General Ban Ki-moon also visited the JW Lee Centre for Strategic
Health Operations (also known as the SHOC room) at WHO headquarters, the centre
of WHO's emergency response.
News is included on the IvyRose website to inform visitors
about current health issues, but not to endorse any particular view or activity.
Any views expressed in the article above are not necessarily those of IvyRose
Ltd.. Material in this news item was released by the World Health Organization
(WHO) on 19 May 2009
and may have been edited (e.g. in style, length, and/or for ease of understanding
by our international readers) for inclusion here. For further information, please
visit their website.
|
